The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells

15:01 EDT 15 Mar 2013 | Nature Publishing

Original Article: The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells

NEXT ARTICLE

More From BioPortfolio on "The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Searches Linking to this Story